Benitec Biopharma Inc Stock price
Is Benitec Biopharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Benitec Biopharma Inc Stock Analysis
Analyst Opinions
13 Analysts have issued a Benitec Biopharma Inc forecast:
Analyst Opinions
13 Analysts have issued a Benitec Biopharma Inc forecast:
Benitec Biopharma Inc Events
Upcoming Event
Don't miss a Thing! We will send you all news about Benitec Biopharma Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Benitec Biopharma Inc Stock News
Company Profile
Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The firms proprietary platforms includes DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy, and Chronic Hepatitis B. The company was founded on April 13, 2020 and is headquartered in Hayward, CA.
| Head office | United States |
| CEO | Dr. Banks |
| Employees | 19 |
| Founded | 2019 |
| Website | benitec.com |


